Proteomic study of Galectin-1 expression in human mesenchymal stem cells

Area of Science:

• Stem cell biology
• Immunology
• Proteomics

Background:

• Bone marrow-derived mesenchymal stem cells (MSCs) interact with hematopoietic stem cells (HSCs) and immune cells.
• MSCs show therapeutic potential for enhancing hematopoietic engraftment and preventing graft-versus-host disease (GVHD).
• Galectin 1 (Gal1) is a protein involved in cell interactions and has known immunomodulatory properties.

Purpose of the Study:

• To investigate the presence and localization of Galectin 1 (Gal1) in human mesenchymal stem cells (hMSCs) using a proteomic approach.
• To determine if Gal1 expression is maintained during hMSC expansion and subculturing.
• To explore the potential role of Gal1 in the immunological functions of hMSCs.

Main Methods:

• Proteomic analysis of human mesenchymal stem cells (hMSCs) in short- and long-term cultures.
• Assessment of Gal1 expression and localization.
• Evaluation of Gal1 presence during subculturing up to five passages.

Main Results:

• Galectin 1 (Gal1) was identified as a major protein expressed in hMSCs.
• Gal1 expression remained stable during hMSC expansion up to five passages.
• Gal1 was found to be secreted and located at the cell surface of hMSCs, involved in extracellular matrix (ECM)-cell interactions.

Conclusions:

• Galectin 1 (Gal1) is a significant component of human mesenchymal stem cells (hMSCs).
• The sustained expression and cell surface localization of Gal1 suggest its involvement in hMSC-mediated cell interactions.
• The immunomodulatory properties of Gal1 indicate its potential role in the immunological functions of hMSCs for therapeutic applications.